ASL Viterbo - Ospedale Belcolle
About ASL Viterbo - Ospedale Belcolle
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute, Naples
4
Abbott Medical Devices
1
Ascelia Pharma AB
1
Calliditas Therapeutics AB
1
Celgene
1
Eli Lilly and Company
1
Fatebenefratelli and Ophthalmic Hospital
1
Heart Care Foundation
1
Italian Society of Nephrology
1
MacroGenics
1
Puma Biotechnology, Inc.
1
Clinical Trials at ASL Viterbo - Ospedale Belcolle
During the past decade, ASL Viterbo - Ospedale Belcolle conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.
2004-03-01
2024-11-01
Active, not recruiting
1,294
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study
2005-02-01
2009-01-01
Completed
1,111
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
2011-03-01
2024-11-01
Active, not recruiting
299
Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients
2012-11-01
2016-11-01
Terminated
284
Clinical Benefits in Optimized Remote HF Patient Management
2011-10-01
2016-09-01
Completed
144
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
2012-08-01
2024-11-01
Active, not recruiting
232
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ASL Viterbo - Ospedale Belcolle" #1 sponsor was "National Cancer Institute, Naples" with 4 trials, followed by "Abbott Medical Devices" with 1 trials
sponsored, "Ascelia Pharma AB" with 1 trials sponsored, "Calliditas Therapeutics AB" with 1 trials sponsored and "Celgene"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ASL Viterbo - Ospedale Belcolle"
#1 collaborator was "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator, "Niguarda Hospital" with 1 trials as a collaborator, "Società Italiana di Nefrologia" with 1 trials as a collaborator and "University of Campania "Luigi Vanvitelli"" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at ASL Viterbo - Ospedale Belcolle
According to Clinical.Site data, the most researched conditions in "ASL Viterbo - Ospedale Belcolle" are
"Breast Cancer" (2 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials), "Breast Neoplasm" (1 trials) and "Chronic Renal Failure" (1 trials). Many other conditions were trialed in "ASL Viterbo - Ospedale Belcolle" in a lesser frequency.
Clinical Trials Intervention Types at ASL Viterbo - Ospedale Belcolle
Most popular intervention types in "ASL Viterbo - Ospedale Belcolle" are "Drug" (13 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cisplatin" (2 trials), "Erlotinib" (2 trials), "Gemcitabine" (2 trials), "Placebo" (2 trials) and "25-OH-D vitamin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ASL Viterbo - Ospedale Belcolle
The vast majority of trials in "ASL Viterbo - Ospedale Belcolle" are
14 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at ASL Viterbo - Ospedale Belcolle
Currently, there are NaN active trials in "ASL Viterbo - Ospedale Belcolle".
undefined are not yet recruiting,
2 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in ASL Viterbo - Ospedale Belcolle,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in ASL Viterbo - Ospedale Belcolle, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".